Clinical Trial: The Purpose of This Study is to Evaluate Efficacy and Safety of NT-101 Eye Drops in Patients With Wet Age-Related Macular Degeneration (AMD)

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07811726) titled 'The Purpose of This Study is to Evaluate Efficacy and Safety of NT-101 Eye Drops in Patients With Wet Age-Related Macular Degeneration (AMD)' on Aug. 28.

Brief Summary: This phase 2 trial is a randomized, double-blind, placebo-controlled, multicenter study in patients with wet AMD to assess the efficacy and safety of NT-101 topical ophthalmic solution (0.20 mM) administered into the study eye twice daily (BID) for 12 weeks.

Study Start Date: June 11

Study Type: INTERVENTIONAL

Condition: Wet Age Related Macular Degeneration

Intervention: DRUG: NT-101 ophthalmic solution

NT-101 is a topical ophthalmic solution containing pigme...